ArticleCancer immunology, immunotherapy : CII2025

Selective JAK2 pathway inhibition enhances anti-leukemic functionality in CD19 CAR-T cells.

Kohei Mitsuno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.